EXTENSE PHARMA
Open bankruptcyA bankruptcy procedure is open for EXTENSE PHARMA according to publications in the Belgian State Gazette; curator: KARL STEINIER.
Summary
The file additionally contains 6 judicial reorganisation notices and 1 administrative flag. The 2021 annual accounts show negative equity (-€437,008) and a net result of -€120,752.
Are you a creditor?
If this company owes you money, you are not paid automatically: you file your claim yourself, within the deadline the judgment sets.
The procedure
- Court
- Enterprise Court of Liège, Namur division
- Declared bankrupt
- 15 December 2022
- Supervising judge
- Renato Sanchioni
- Official Gazette
- 21-12-2022 (pdf) ↗search the document for 2022/147629
Deadlines
- Appeal or third-party opposition until
- passed on 5 January 2023Fifteen days after the publication in the Official Gazette.art. XX.108 CEL
- File the claim in RegSol until
- passed on 14 January 2023art. XX.104 and XX.155 CEL
- First verification report
- passed on 25 January 2023Goods that belong to you, such as those delivered under retention of title, are reclaimed before this day.art. XX.104 and XX.194 CEL
- Late claim until
- passed on 15 December 2023Late, you share only in what has not been paid out yet, and the costs are yours.art. XX.165 CEL
Curator
- Karl SteinierRue Des Faucons 61, 5004 Bougek.steinier@wallaw.be
What to do now
- Do not deliver on credit any more without an agreement with the curator.
- Gather your documents: invoices, purchase orders, contract, delivery notes and reminders.
- File your proof of claim in RegSol (regsol.be), yourself with eID or itsme, or through your lawyer. State principal, interest and costs separately, and any preferential right you hold.
- Delivered under retention of title? Reclaim your goods before the first report on the verification of claims.
- Ask your accountant about the VAT on the unpaid invoices: in a bankruptcy it can be recovered under conditions.
- Follow the file in RegSol: the verification report (admitted or disputed) and the curator's reports appear there.
The deadlines above come from the publication of the judgment. Check them in RegSol before you file anything; a passed deadline no longer applies.
General information, not legal advice. If in doubt, the curator, your lawyer or your accountant can help.Creditor guide for this company
Embed in an article
Writing about this bankruptcy? Put the card of EXTENSE PHARMA in your article: name, enterprise number, its status in the KBO and the latest annual accounts, with a link to this dossier.
- Stays current: the status follows the register, the figures are those of the latest filed accounts. No Checked score or verdict.
- Light on your page: one small script and one data request, also answered from a cache; no cookies, no tracking.
- Where scripts do not run (a newsletter, a feed reader) a plain link remains.
Signals
This company filed its last 3 accounts on average 327 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
History
Go further with this company
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2021, micro schema
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
| Line | 2018 | 2019 | 2020 | 2021 | Change |
|---|---|---|---|---|---|
| Turnover70 | €1.4m | - | - | - | - |
| Remuneration, social security and pensions62 | - | - | €260 | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €44,696 | €68,184 | €58,378 | €57,460 | ▼ 1.6% |
| Other operating charges640/8 | - | - | €1,331 | €50 | ▼ 96.2% |
| Gross operating margin9900 | -€88,269 | -€280,585 | €19,652 | -€42,955 | ▼ 319% |
| Operating profit (loss)9901 | -€136,831 | -€350,936 | -€40,318 | -€100,466 | ▼ 149% |
| Financial income75/76B | - | - | €1 | - | - |
| Recurring financial income75 | €1 | €1 | €1 | - | - |
| Financial charges65/66B | - | - | €20,861 | €20,287 | ▼ 2.8% |
| Recurring financial charges65 | €16,293 | €27,815 | €20,861 | €20,287 | ▼ 2.8% |
| Profit (loss) for the period before taxes9903 | -€153,123 | -€378,750 | -€61,178 | -€120,752 | ▼ 97.4% |
| Income taxes67/77 | €6 | €953 | €795 | - | - |
| Profit (loss) for the period9904 | -€153,129 | -€379,703 | -€61,973 | -€120,752 | ▼ 94.8% |
| Profit (loss) for the period to be appropriated9905 | -€153,129 | -€379,703 | -€61,973 | -€120,752 | ▼ 94.8% |
| Line | 2018 | 2019 | 2020 | 2021 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €1.4m | €846,193 | €456,010 | €394,215 | ▼ 13.6% |
| Fixed assets21/28 | €275,901 | €207,717 | €149,339 | €91,879 | ▼ 38.5% |
| Intangible fixed assets21 | €268,762 | €200,942 | €142,661 | €85,201 | ▼ 40.3% |
| Tangible fixed assets22/27 | €461 | €98 | €0 | - | - |
| Furniture and vehicles24 | - | - | €0 | - | - |
| Financial fixed assets28 | €6,678 | €6,678 | €6,678 | €6,678 | = |
| Current assets29/58 | €1.1m | €638,475 | €306,671 | €302,337 | ▼ 1.4% |
| Stocks and contracts in progress3 | €186,000 | €171,000 | €171,000 | €171,000 | = |
| Stocks30/36 | - | - | €171,000 | €171,000 | = |
| Amounts receivable within one year40/41 | €905,586 | €467,394 | €135,069 | €131,254 | ▼ 2.8% |
| Other amounts receivable41 | - | - | €135,069 | €131,254 | ▼ 2.8% |
| Cash at bank and in hand54/58 | €56,879 | €82 | €603 | €83 | ▼ 86.3% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €1.4m | €846,193 | €456,010 | €394,215 | ▼ 13.6% |
| Equity10/15 | €125,420 | -€254,283 | -€316,256 | -€437,008 | ▼ 38.2% |
| Contributions10/11 | €168,600 | - | €168,600 | €168,600 | = |
| Reserves13 | €20,363 | €20,363 | €20,363 | €20,363 | = |
| Non-distributable reserves130/1 | - | - | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | - | - | €1,860 | €1,860 | = |
| Distributable reserves133 | - | - | €18,503 | €18,503 | = |
| Profit (loss) carried forward14 | -€63,542 | -€443,246 | -€505,218 | -€625,971 | ▼ 23.9% |
| Amounts payable17/49 | €1.3m | €1.1m | €772,266 | €831,224 | ▲ 7.6% |
| Amounts payable after more than one year17 | - | €255,254 | €186,316 | €115,624 | ▼ 37.9% |
| Financial debts170/4 | - | - | €186,316 | €115,624 | ▼ 37.9% |
| Amounts payable within one year42/48 | €1.3m | €845,221 | €585,950 | €715,600 | ▲ 22.1% |
| Current portion of amounts payable after more than one year42 | - | - | €93,404 | €164,707 | ▲ 76.3% |
| Financial debts43 | - | - | €101,073 | €187,909 | ▲ 85.9% |
| Credit institutions430/8 | - | - | €101,073 | €187,909 | ▲ 85.9% |
| Trade debts44 | €417,237 | €415,537 | €152,515 | €116,803 | ▼ 23.4% |
| Suppliers440/4 | - | - | €152,515 | €116,803 | ▼ 23.4% |
| Other amounts payable47/48 | - | - | €238,958 | €246,181 | ▲ 3.0% |
| Line | 2018 | 2019 | 2020 | 2021 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€153,129 | -€379,703 | -€61,973 | -€120,752 | ▼ 94.8% |
| + Depreciation and write-downs630 | €44,696 | €68,184 | €58,378 | €57,460 | ▼ 1.6% |
| Operating cash flow (approximation) | -€108,432 | -€311,519 | -€3,595 | -€63,292 | ▼ 1,661% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | - |
| Change in cash | - | -€56,797 | €521 | -€520 | ▼ 200% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Show earlier events
About the unread acts
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
1 establishment unit
2 parcels
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25055C0308/00C003 | Wallonia | 1,756 m² | 1 · 250 m² | - |
| 25087C0509/00V002 | Wallonia | 967 m² | 1 · 98 m² | - |
Linked by address, not proof of ownership
Insolvency mandates
1 mandate| Role | Name | Tenure |
|---|---|---|
| Curator | KARL STEINIER RUE DES FAUCONS 61, 5004 BOUGE- |
15-12-2022 → present |
Similar companies · same sector, comparable size
Identification & contact
No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.